4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-004327
Chief Technology Officer sold 20,000 shares at $11.03 ($220,600)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming Chief Technology Officer | 2023-01-19 | Sale | −20,000 | $11.03 | $220,600 | 7,946,833 | D |
| Open-market sales · 20,000 sh · avg $11.03 · $220,600 | |||||||
Loading xslF345X03/doc4.xml…